GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Genomic Health, Inc. (GHDX) [hlAlert]

Rating:
Buy GHDX
up 51.01 %

Genomic Health, Inc. (GHDX) rated Buy by ThinkEquity

Posted on: Friday,  Jan 8, 2010  11:25 AM ET by ThinkEquity

ThinkEquity rated Buy Genomic Health, Inc. (NASDAQ: GHDX) on 01/08/2010, when the stock price was $17.70. Since
then, Genomic Health, Inc. has gained 51.02% as of 01/06/2016's recent price of $26.73.
If you would have followed this ThinkEquity's recommendation on GHDX, you would have gained 51.01% of your investment in 2189 days.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2010 11:25 AM Buy
None
17.70
as of 12/31/2010
1 Week down  -5.76 %
1 Month up  16.96 %
3 Months up  61.52 %
1 YTD up  21.92 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy